HKSH Medical Group Signed Memorandum of Understanding with Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen To Advance Precision Proton Therapy, Furthering the Healthy China Initiative
In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center,HKSH Medical Group (“HKSH”) and Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen (“Shenzhen Cancer Hospital”) signed a memorandum of understanding (“MOU”) on 11 December 2025. The MOU was signed by Dr. Walton LI, Chief Executive Officer of […]